121 related articles for article (PubMed ID: 1306105)
1. Levels of colorectal ornithine decarboxylase activity in patients with colon cancer, a family history of nonpolyposis hereditary colorectal cancer, and adenomas.
Love RR; Surawicz TS; Morrissey JF; Verma AK
Cancer Epidemiol Biomarkers Prev; 1992; 1(3):195-8. PubMed ID: 1306105
[TBL] [Abstract][Full Text] [Related]
2. A randomized, placebo-controlled trial of low-dose alpha-difluoromethylornithine in individuals at risk for colorectal cancer.
Love RR; Jacoby R; Newton MA; Tutsch KD; Simon K; Pomplun M; Verma AK
Cancer Epidemiol Biomarkers Prev; 1998 Nov; 7(11):989-92. PubMed ID: 9829706
[TBL] [Abstract][Full Text] [Related]
3. Ornithine decarboxylase and polyamines in colorectal neoplasia and mucosa.
Hixson LJ; Garewal HS; McGee DL; Sloan D; Fennerty MB; Sampliner RE; Gerner EW
Cancer Epidemiol Biomarkers Prev; 1993; 2(4):369-74. PubMed ID: 8348060
[TBL] [Abstract][Full Text] [Related]
4. Low colonic glutathione detoxification capacity in patients at risk for colon cancer.
Grubben MJ; van den Braak CC; Nagengast FM; Peters WH
Eur J Clin Invest; 2006 Mar; 36(3):188-92. PubMed ID: 16506964
[TBL] [Abstract][Full Text] [Related]
5. Ornithine decarboxylase as a marker for colorectal polyps and cancer.
Luk GD; Moshier JA; Ehrinpreis MN
Prog Clin Biol Res; 1988; 279():227-39. PubMed ID: 3054922
[TBL] [Abstract][Full Text] [Related]
6. Ornithine decarboxylase: an unreliable marker for the identification of population groups at risk for colonic neoplasia.
Braverman DZ; Stankiewicz H; Goldstein R; Patz JK; Morali GA; Jacobsohn WZ
Am J Gastroenterol; 1990 Jun; 85(6):723-6. PubMed ID: 2353692
[TBL] [Abstract][Full Text] [Related]
7. Sources of variability in estimating ornithine decarboxylase activity and polyamine contents in human colorectal mucosa.
Hixson LJ; Emerson SS; Shassetz LR; Gerner EW
Cancer Epidemiol Biomarkers Prev; 1994 Jun; 3(4):317-23. PubMed ID: 8061580
[TBL] [Abstract][Full Text] [Related]
8. Frequency and type of colorectal tumors in asymptomatic high-risk individuals in families with hereditary nonpolyposis colorectal cancer.
Ponz de Leon M; Della Casa G; Benatti P; Percesepe A; di Gregorio C; Fante R; Roncucci L
Cancer Epidemiol Biomarkers Prev; 1998 Jul; 7(7):639-41. PubMed ID: 9681535
[TBL] [Abstract][Full Text] [Related]
9. Synchronous colorectal neoplasms in patients with colorectal cancer: predisposing individual and familial factors.
Piñol V; Andreu M; Castells A; Payá A; Bessa X; Jover R;
Dis Colon Rectum; 2004 Jul; 47(7):1192-200. PubMed ID: 15164252
[TBL] [Abstract][Full Text] [Related]
10. Ornithine decarboxylase and polyamines in familial adenomatous polyposis.
Giardiello FM; Hamilton SR; Hylind LM; Yang VW; Tamez P; Casero RA
Cancer Res; 1997 Jan; 57(2):199-201. PubMed ID: 9000553
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of adenomas among young individuals at average risk for colorectal cancer.
de Jong AE; Morreau H; Nagengast FM; Mathus-Vliegen EM; Kleibeuker JH; Griffioen G; Cats A; Vasen HF
Am J Gastroenterol; 2005 Jan; 100(1):139-43. PubMed ID: 15654793
[TBL] [Abstract][Full Text] [Related]
12. Polyamine levels of human colorectal adenocarcinomas are correlated with tumor stage and grade.
Weiss TS; Bernhardt G; Buschauer A; Thasler WE; Dolgner D; Zirngibl H; Jauch KW
Int J Colorectal Dis; 2002 Nov; 17(6):381-7. PubMed ID: 12355213
[TBL] [Abstract][Full Text] [Related]
13. Colon ornithine decarboxylase activity following standard endoscopy preparation regimens.
Love RR; Verma AK; Surawicz TS; Morrissey JF
J Surg Oncol; 1989 Nov; 42(3):150-3. PubMed ID: 2554065
[TBL] [Abstract][Full Text] [Related]
14. Polyamine depletion by ODC-AdoMetDC antisense adenovirus impairs human colorectal cancer growth and invasion in vitro and in vivo.
Zhang B; Liu XX; Zhang Y; Jiang CY; Hu HY; Gong L; Liu M; Teng QS
J Gene Med; 2006 Aug; 8(8):980-9. PubMed ID: 16783835
[TBL] [Abstract][Full Text] [Related]
15. [Serum concentration of insulin, C-peptide and insulin-like growth factor I in patients with colon adenomas and colorectal cancer].
Kaczka A; Kumor A; Pietruczuk M; Małecka-Panas E
Pol Merkur Lekarski; 2007 May; 22(131):373-5. PubMed ID: 17679371
[TBL] [Abstract][Full Text] [Related]
16. Increased mucosal ornithine decarboxylase activity in human gastric cancer.
Okuzumi J; Yamane T; Kitao Y; Tokiwa K; Yamaguchi T; Fujita Y; Nishino H; Iwashima A; Takahashi T
Cancer Res; 1991 Mar; 51(5):1448-51. PubMed ID: 1997184
[TBL] [Abstract][Full Text] [Related]
17. Rectal aberrant crypt foci identified using high-magnification-chromoscopic colonoscopy: biomarkers for flat and depressed neoplasia.
Hurlstone DP; Karajeh M; Sanders DS; Drew SK; Cross SS
Am J Gastroenterol; 2005 Jun; 100(6):1283-9. PubMed ID: 15929758
[TBL] [Abstract][Full Text] [Related]
18. Association between high levels of ornithine decarboxylase activity and favorable prognosis in human colorectal carcinoma.
Matsubara N; Hietala OA; Gilmour SK; Yum KY; Litwin S; Watts P; Brennan ; O'Brien
Clin Cancer Res; 1995 Jun; 1(6):665-71. PubMed ID: 9816030
[TBL] [Abstract][Full Text] [Related]
19. Clinical management of hereditary nonpolyposis colon cancer. High-risk clinics and registries.
Lynch P; Winn RJ
Hematol Oncol Clin North Am; 1989 Mar; 3(1):75-86. PubMed ID: 2917964
[TBL] [Abstract][Full Text] [Related]
20. Methodological problems in the use of rectal cell proliferation as a biomarker of colorectal cancer risk.
Biasco G; Paganelli GM; Santucci R; Brandi G; Barbara L
J Cell Biochem Suppl; 1994; 19():55-60. PubMed ID: 7823606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
